Tenable Recognized as a Cyber AI Leader on the First-Ever CRN AI 100 List
COLUMBIA, Md., April 08, 2024 (GLOBE NEWSWIRE) — Tenable®, the Exposure Management company, today announced it has been recognized by […]
Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting
PHILADELPHIA, April 08, 2024 (GLOBE NEWSWIRE) — Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell […]
Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlights
BOSTON, April 08, 2024 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of […]
Magnite to Announce First Quarter 2024 Financial Results on May 8, 2024
NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) — Magnite (Nasdaq: MGNI), the world’s largest independent sell-side advertising company, will announce […]
WEYCO Group, Inc. First Quarter 2024 Earnings Conference Call
MILWAUKEE, WI, April 08, 2024 (GLOBE NEWSWIRE) — WEYCO Group, Inc. (NASDAQ: WEYS), a global marketer of footwear, plans to […]
Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical Study
RAS-mutated mCRC – In RAS-mutated mCRC, novel preclinical finding demonstrates onvansertib inhibits the tumor’s ability to adapt to hypoxia resulting in […]
NN, Inc. Announces Another Strong Quarter of New Business Awards at $17.2 million in Q1 2024
CHARLOTTE, N.C., April 08, 2024 (GLOBE NEWSWIRE) — NN, Inc. (NASDAQ: NNBR), a global diversified industrial company that engineers and […]
Shockwave Reducer Demonstrates Consistent, Positive Results in ‘Real-World’ Study
SANTA CLARA, Calif., April 08, 2024 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and […]
Kineta Reports Initial Clinical Response Data at AACR 2024 of its Ongoing Phase 1/2 VISTA-101 Clinical Trial
Partial response and stable disease reported in combination cohort, and durable stable disease observed in monotherapy cohorts Favorable clinical safety […]
Astec Industries, Inc. (NASDAQ: ASTE) Announces the Company’s First Quarter Conference Call on May 1, 2024 at 8:30 A.M. Eastern Time
CHATTANOOGA, Tenn., April 08, 2024 (GLOBE NEWSWIRE) — You are invited by Astec Industries, Inc. (NASDAQ:ASTE) to participate in a […]
